LOCOID Drug Patent Profile
✉ Email this page to a colleague
When do Locoid patents expire, and what generic alternatives are available?
Locoid is a drug marketed by Bausch, Yamanouchi, and Precision Dermat. and is included in eight NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in LOCOID is hydrocortisone butyrate. There are sixty-seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Locoid
A generic version of LOCOID was approved as hydrocortisone butyrate by TARO PHARM INDS on January 14th, 2004.
Summary for LOCOID
| US Patents: | 2 |
| Applicants: | 3 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 56 |
| Clinical Trials: | 4 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LOCOID |
| What excipients (inactive ingredients) are in LOCOID? | LOCOID excipients list |
| DailyMed Link: | LOCOID at DailyMed |
Recent Clinical Trials for LOCOID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LEO Pharma | Phase 1 |
| Icahn School of Medicine at Mount Sinai | N/A |
| St. Luke's-Roosevelt Hospital Center | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for LOCOID
Paragraph IV (Patent) Challenges for LOCOID
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| LOCOID | Lotion | hydrocortisone butyrate | 0.10% | 022076 | 1 | 2016-08-31 |
US Patents and Regulatory Information for LOCOID
LOCOID is protected by two US patents.
Patents protecting LOCOID
Stabilized steroid composition and method for its preparation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Stabilized steroid composition and method for its preparation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | LOCOID | hydrocortisone butyrate | CREAM;TOPICAL | 018514-001 | Mar 31, 1982 | AB1 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
| Bausch | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019116-001 | Feb 25, 1987 | AT | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
| Bausch | LOCOID | hydrocortisone butyrate | LOTION;TOPICAL | 022076-001 | May 18, 2007 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
| Yamanouchi | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019819-001 | Sep 15, 1988 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Yamanouchi | LOCOID | hydrocortisone butyrate | CREAM;TOPICAL | 018795-001 | Jan 7, 1983 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Bausch | LOCOID | hydrocortisone butyrate | LOTION;TOPICAL | 022076-001 | May 18, 2007 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
| Yamanouchi | LOCOID | hydrocortisone butyrate | OINTMENT;TOPICAL | 019106-001 | Jul 3, 1984 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Premature patent expiration for: LOCOID
Expiration due to failure to pay maintenance fee
| Patent Number | Tradename | Expiration Date |
|---|---|---|
| See Plans and Pricing | LOCOID | See Plans and Pricing |
